| 000 | 01159 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250513113403.0 | ||
| 264 | 0 | _c19970410 | |
| 008 | 199704s 0 0 eng d | ||
| 022 | _a0028-3878 | ||
| 024 | 7 |
_a10.1212/wnl.48.3_suppl_3.21s _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFerrari, M D | |
| 245 | 0 | 0 |
_a311C90: increasing the options for therapy with effective acute antimigraine 5HT1B/1D receptor agonists. _h[electronic resource] |
| 260 |
_bNeurology _cMar 1997 |
||
| 300 |
_aS21-4 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Review | ||
| 650 | 0 | 4 |
_aHeadache _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMigraine Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aOxazoles _xadverse effects |
| 650 | 0 | 4 | _aOxazolidinones |
| 650 | 0 | 4 | _aReceptor, Serotonin, 5-HT1B |
| 650 | 0 | 4 | _aReceptor, Serotonin, 5-HT1D |
| 650 | 0 | 4 |
_aReceptors, Serotonin _xphysiology |
| 650 | 0 | 4 |
_aSerotonin Receptor Agonists _xadverse effects |
| 650 | 0 | 4 | _aTryptamines |
| 773 | 0 |
_tNeurology _gvol. 48 _gno. 3 Suppl 3 _gp. S21-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.48.3_suppl_3.21s _zAvailable from publisher's website |
| 999 |
_c9058539 _d9058539 |
||